Replies to post #88851 on US Stem Cell Inc (USRM)

[docprep]

Despite what "some" say.

Increased revenues and depleting debts ARE increases earnings. Which has happened 6 straight quarters. They're not losses.

In an emerging market. With major expansions occurred and in the works.